Icon (ICLR) Other Non-Current Assets (2009 - 2026)
Icon's (ICLR) quarterly Other Non-Current Assets came in at $117.4 million in Q2 2026, up 45.61% year-over-year from $80.6 million in Q2 2025, and up 27.9% quarter-over-quarter from $91.8 million in Q1 2026.
Analysis
Icon (ICLR) Other Non-Current Assets (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Other Non-Current Assets for 18 consecutive years, with $117.4 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Non-Current Assets rose 45.61% year-over-year to $117.4 million in Q2 2026; TTM through Jun 2026 was $117.4 million, a 45.61% increase from a year earlier, with the FY2025 full-year figure at $116.8 million, up 60.38% from the prior year.
- Other Non-Current Assets was $117.4 million for Q2 2026 at Icon, up from $91.8 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $143.7 million in Q1 2023 and troughed at $60.2 million in Q1 2022.
- A 5-year average of $89.8 million and a median of $81.7 million in 2024 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets soared 138.62% in 2023 and plunged 46.68% in 2024, its largest moves.
- Over 5 years, Other Non-Current Assets stood at $76.9 million in 2022, then retreated by 14.39% to $65.8 million in 2023, then grew by 10.64% to $72.8 million in 2024, then soared by 60.38% to $116.8 million in 2025, then rose by 0.57% to $117.4 million in 2026.
- The last three Other Non-Current Assets figures came in at $117.4 million (Q2 2026), $91.8 million (Q1 2026), and $116.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 558.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 25.20 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 117.41 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 587.56 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 91.80 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 1.28 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 87.48 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 201,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 91,801.74 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 143,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 117.41 Mn |
| Mar 31, 2026 | 91.80 Mn |
| Dec 31, 2025 | 116.75 Mn |
| Sep 30, 2025 | 91.02 Mn |
| Jun 30, 2025 | 80.64 Mn |
| Mar 31, 2025 | 87.49 Mn |
| Dec 31, 2024 | 72.80 Mn |
| Sep 30, 2024 | 82.76 Mn |
| Jun 30, 2024 | 78.11 Mn |
| Mar 31, 2024 | 76.64 Mn |
| Dec 31, 2023 | 65.80 Mn |
| Sep 30, 2023 | 121.69 Mn |
| Jun 30, 2023 | 129.10 Mn |
| Mar 31, 2023 | 143.73 Mn |
| Dec 31, 2022 | 76.86 Mn |
| Sep 30, 2022 | 60.25 Mn |
| Jun 30, 2022 | 63.84 Mn |
| Mar 31, 2022 | 60.23 Mn |
| Dec 31, 2021 | 76.80 Mn |
| Sep 30, 2021 | 60.38 Mn |